(Co-located with Antibodies Europe, 22-23 October)

Protein Expression Sessions

KEYNOTE PRESENTATION
Biomanufacturing from Tobacco Biomass: Upstream and Downstream Processing Challenges
Karen K. Oishi, Ph.D., Associate Principal Scientist, Research & Development, Philip Morris International
Tobacco has proven to be an host system able to support the production of a great diversity of proteins from microbial to human sources. One of the challenges facing this system is the development of a robust and reliable manufacturing platform that delivers a quality and safe product.

Great strides have been made in the expression of proteins for structure and characterization studies, as well as for therapeutics and diagnostics.  However, with these strides have come new obstacles.  Higher throughput expression and purification, as well as more flexible expression systems and techniques are in even greater demand now to support the needs of the research pipeline.  It has become even more important to prevent problems in protein expression by wise choices in data analysis well before the task goes into the laboratory.  This conference will explore the newest data and innovations relating to the expression and characterization of proteins for biological understanding and therapeutics, in addition to strategies to make the eventual scaled-up expression of these proteins more effective, efficient and trouble-free.

Scientific Advisory Board
François Arcand, MBA, ERA Biotech
Jean-Luc Lenormand, Ph.D., CHU Grenoble
Paul Ramage, Ph.D., Novartis
Stefan R. Schmidt, Ph.D., AstraZeneca
Trevor Wilkinson, Ph.D., MedImmune, Inc.